Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies often cause serious skin problems that need careful management.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Hirsutism causes significant psychological distress in women.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

A woman's ovarian fibroma caused high testosterone levels, which normalized after surgery.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Platelet-rich plasma treatment is more effective and cost-efficient than epinephrine for healing bleeding peptic ulcers, with fewer complications and rebleeding cases.

The follicular unit extraction method for hair transplants is a technique with benefits and drawbacks.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Activating Sonic Hedgehog signaling in cancer stroma may help treat basal cell carcinoma.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.